Korea South
Daewoong Pharmaceutical, founded in 1945, is a leading healthcare company in Korea, renowned for its innovative approaches in the pharmaceutical industry. The company has positioned itself as the No.1 GI and endocrine pharma, continuously investing in R&D to create first-in-class and best-in-class medicines that cater to the global market.
With a diverse pipeline and next-generation platform technologies, Daewoong Pharmaceutical remains committed to its vision of developing groundbreaking drugs and has earned certifications from major regulatory authorities, including the U.S. FDA and the EMA. These certifications affirm the company’s adherence to international quality, environmental management, and occupational health standards.
The company nurtures its workforce through smart work practices and global talent training programs, fostering a corporate culture geared towards innovation. As Daewoong continues to expand its global footprint, it seeks to deliver tangible health advancements and improve the quality of life worldwide. Despite a rich history and robust strategic vision, specific recent investment details remain undisclosed.
